Invitae (NVTA) Gross Profit Margin starting from the third quarter 2023 to third quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Invitae Corporation  (NYSE: NVTA)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Invitae's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVTA Gross Profit Margin (Sep 30 2023)
Q3 		(Jun 30 2023)
Q2 		(Mar 31 2023)
Q1 		(Dec 31 2022)
Q4 		(Sep 30 2022)
Q3
Y / Y Revenue Change -9.21 %
Seq. Revenue Change 0.59 %
Revenue In Millions $121.24
Gross Profit Margin 32.21 %
Gross Profit Margin Total Ranking # 2613
Gross Profit In Millions $39.06
Y / Y Gross Profit Change 135.55 %
Seq. Gross Profit Change 18.14 %


Commenting Third Quarter 2023 Gross Profit Margin
Invitae Corporation Gross Profit grew by 18.14 % in Q3 sequentially to 39 millions, while Revenue increased by 0.59 %, this led to improvement in the company's Gross Profit Margin to 32.21 %, above the Invitae Corporation average Gross Profit Margin.


Observing third quarter 2023 results within Medical Laboratories industry 24 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2613, from total ranking in the previous quarter at 2931.
Learn about Gross Margin
NVTA's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 25
Healthcare Sector # 431
Overall # 2573

Gross Profit Margin Statistics
High Average Low
53.39 % 28.46 % 7.01 %
(Dec 31 2018)   (Jun 30 2020)


NVTA Gross Income Trends • More of NVTA's Profitabilty Ratios • NVTA Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NVTA's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NVTA's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NVTA's Competitors
Gross Profit Margin Profit Margin for Invitae's Suppliers
Gross Profit Margin Profit Margin for NVTA's Customers

You may also want to know
NVTA's Annual Growth Rates NVTA's Profitability Ratios NVTA's Asset Turnover Ratio NVTA's Dividend Growth
NVTA's Roe NVTA's Valuation Ratios NVTA's Financial Strength Ratios NVTA's Gross Profit Growth
NVTA's Roa NVTA's Inventory Turnover Ratio NVTA's Growth Rates NVTA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2023, within Medical Laboratories Industry Gross Profit MarginSep 30 2023 MRQ Gross ProfitSep 30 2023 MRQ Revenue
Castle Biosciences Inc   81.59 %$ 50.174  Millions$ 61.493  Millions
Caredx Inc   80.33 %$ 53.975  Millions$ 67.192  Millions
Veracyte Inc   75.78 %$ 68.281  Millions$ 90.108  Millions
Bioaffinity Technologies Inc   74.97 %$ 0.224  Millions$ 0.298  Millions
Exact Sciences Corporation  73.27 %$ 461.877  Millions$ 630.403  Millions
Inotiv Inc   70.88 %$ 99.751  Millions$ 140.740  Millions
Nrc Health  61.44 %$ 23.312  Millions$ 37.945  Millions
Butterfly Network Inc   60.99 %$ 9.382  Millions$ 15.382  Millions
Luna Innovations Inc  57.56 %$ 17.629  Millions$ 30.629  Millions
Exagen Inc   57.44 %$ 7.706  Millions$ 13.416  Millions
Somalogic Inc   54.67 %$ 12.054  Millions$ 22.048  Millions
Hologic Inc  52.92 %$ 500.300  Millions$ 945.300  Millions
Ispecimen inc   49.87 %$ 1.385  Millions$ 2.778  Millions
Ge Healthcare Technologies Inc   48.24 %$ 1,935.000  Millions$ 4,011.000  Millions
Fulgent Genetics Inc   47.52 %$ 39.844  Millions$ 83.844  Millions
Natera Inc   45.23 %$ 121.344  Millions$ 268.306  Millions
Charles River Laboratories International inc   42.77 %$ 439.063  Millions$ 1,026.623  Millions
American Shared Hospital Services  41.20 %$ 2.102  Millions$ 5.102  Millions
Psychemedics Corporation  41.07 %$ 2.091  Millions$ 5.091  Millions
Science 37 Holdings Inc   39.73 %$ 5.915  Millions$ 14.887  Millions
Iqvia Holdings Inc   35.06 %$ 1,310.000  Millions$ 3,736.000  Millions
Quest Diagnostics Inc  32.85 %$ 754.000  Millions$ 2,295.000  Millions
Invitae Corporation  32.21 %$ 39.055  Millions$ 121.241  Millions
Labcorp Holdings Inc   27.85 %$ 851.200  Millions$ 3,056.800  Millions
Medpace Holdings Inc   27.04 %$ 133.193  Millions$ 492.499  Millions
Personalis Inc   19.08 %$ 3.481  Millions$ 18.247  Millions
Fortrea Holdings Inc   16.63 %$ 129.100  Millions$ 776.400  Millions
Bionexus Gene Lab Corp   13.88 %$ 0.354  Millions$ 2.554  Millions
Akumin Inc   12.50 %$ 22.577  Millions$ 180.624  Millions
Capforce Inc   11.48 %$ 0.080  Millions$ 0.699  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.